N
novellia.com
The era of digitomics is here
About novellia.com
Novellia, Inc. is a New York-based health technology company operating an AI-enabled platform designed to centralize and manage personal health data. The company was founded in 2023 by CEO Shashi Shankar and Chief Medical Officer Dr. Abe Abraham, both former employees of Genentech. The inspiration for the company came from Shankar's personal experience with his grandfather's late-stage cancer diagnosis, where fragmented health records hindered timely and precise care. Shankar's background is in health policy and global digital health at Roche, while Dr. Abraham has experience as a drug developer. They are joined by technical co-founder and CTO Elliot Katz, an early engineer at Zocdoc.
Read full description
The core of Novellia's business is a free-to-use personal health portal for patients in the US. This platform allows individuals to aggregate their complete medical records from tens of thousands of healthcare systems, including doctor's notes, test results, and insurance claims, into a single, secure, and continuously updated profile. The service aims to solve the problem of fragmented health data by leveraging API technology and a custom-built rules engine to normalize and de-duplicate information. Beyond record consolidation, the platform provides users with personalized educational content about their conditions and medications and matches them with suitable clinical trials.
Novellia's business model does not charge patients. Revenue is generated by licensing access to aggregated, anonymized real-world data to its primary clients: life science and biopharmaceutical companies. These clients use the rich, longitudinal datasets to gain insights into the patient journey, treatment efficacy, and care gaps, which informs research, development, and commercial strategies. This data-licensing model provides these organizations with a comprehensive view that can accelerate research and reduce costs associated with data acquisition and tokenization. The company has engaged with top global biopharma companies as customers and partners with patient advocacy groups to better understand the patient experience. In 2025, Novellia was recognized by Digital Health New York as a "Startup to Watch" and won a MedTech Breakthrough Award for "Best Electronic Health Record Service".
Latest news
Press, funding announcements and product moves mentioning novellia.com.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2026 | $18M | $72M | Spark Capital | ↗ |
Growth signals
Latest recorded traffic for novellia.com is 230K monthly website visits, up 228.6% over the last three months. novellia.com's team grew 216.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Other known investors2 additional known investors
Bling Capital
TMV
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about novellia.com on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See novellia.com’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








